kynurenine has been researched along with DDPAC in 1 studies
Kynurenine: A metabolite of the essential amino acid tryptophan metabolized via the tryptophan-kynurenine pathway.
kynurenine : A ketone that is alanine in which one of the methyl hydrogens is substituted by a 2-aminobenzoyl group.
Excerpt | Relevance | Reference |
---|---|---|
"Exploring the neurochemical continuum between frontotemporal dementia (FTD) and amyotrophic lateral sclerosis (ALS) with respect to monoamines and kynurenines in cerebrospinal fluid (CSF) and serum, may be useful to identify possible new research/therapeutic targets." | 3.96 | Monoaminergic and Kynurenergic Characterization of Frontotemporal Dementia and Amyotrophic Lateral Sclerosis in Cerebrospinal Fluid and Serum. ( De Deyn, PP; Janssens, J; Kema, IP; van der Ley, C; van Faassen, M; Vermeiren, Y, 2020) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Janssens, J | 1 |
Vermeiren, Y | 1 |
van Faassen, M | 1 |
van der Ley, C | 1 |
Kema, IP | 1 |
De Deyn, PP | 1 |
1 other study available for kynurenine and DDPAC
Article | Year |
---|---|
Monoaminergic and Kynurenergic Characterization of Frontotemporal Dementia and Amyotrophic Lateral Sclerosis in Cerebrospinal Fluid and Serum.
Topics: Aged; Amyotrophic Lateral Sclerosis; Biogenic Monoamines; Biomarkers; Female; Frontotemporal Dementi | 2020 |